Zealand Pharma A/S
No trades
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported −5.58 DKK per share, beating the −8.85 DKK estimate by 36.97%. Revenue for the same period reached 34.00 M DKK, despite the estimate of 18.23 M DKK. For the next quarter, analysts expect 0.94 DKK in earnings per share and 4.54 B DKK in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise